Anaptysbio Inc (ANAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 108,249 | 76,320 | 22,263 | 27,771 | 43,113 |
| Gross Profit | 108,249 | 76,320 | 22,263 | 27,771 | 43,113 |
| Operating Expenses | 41,348 | 41,616 | 48,433 | 55,310 | 52,783 |
| Operating Income | 66,901 | 34,704 | -26,170 | -27,539 | -9,670 |
| Other Income | -17,206 | -19,591 | -12,421 | -11,746 | -12,120 |
| Pre-tax Income | 49,695 | 15,113 | -38,591 | -39,285 | -21,790 |
| Income Tax | 81 | N/A | 39 | 44 | -6 |
| Net Income Continuous | 49,614 | 15,113 | -38,630 | -39,329 | -21,784 |
| Net Income | $49,614 | $15,113 | $-38,630 | $-39,329 | $-21,784 |
| EPS Basic Total Ops | 1.62 | 0.54 | -1.34 | -1.28 | -0.63 |
| EPS Basic Continuous Ops | 1.62 | 0.54 | -1.34 | -1.28 | -0.64 |
| EPS Diluted Total Ops | 1.64 | 0.52 | -1.34 | -1.28 | -0.63 |
| EPS Diluted Continuous Ops | 1.64 | 0.52 | -1.34 | -1.28 | -0.64 |
| EPS Diluted Before Non-Recurring Items | 1.58 | 0.52 | -1.34 | -1.28 | -0.72 |
| EBITDA(a) | $67,167 | $34,184 | $-27,166 | $-28,600 | $-11,371 |